ICAD studies we will be reporting on include the results of two large studies examining the impact of docosahexanoic acid (DHA), an Omega-3 fatty acid found in fish and algae, on Alzheimer’s and cognitive performance. In addition to therapy trials, results from a broad range of studies will be presented at ICAD 2009, including:

[…]

Utahns who rely on Medicaid to pay for their prescription drugs may find it more difficult to get a popular medication used to treat Alzheimer’s disease.

On July 1, the state will implement a drug list that gives preference to Namenda and Exelon, two other Alzheimer’s disease medications. The drugs were judged as safe […]

The first great bit of news we’d like to announce is the launch of this brand new website 4abettermemory.com for all those desiring to know more about what they can do to both maintain their brain and enhance cognitive functioning, with or without Alzheimer’s and related dementias. We especially want to share practical information regarding […]

Dave Larsen the content manager for this website will be speaking in a variety of location in the Utah area over the next 4 weeks. For a listing of these go to our calendar of events. If you would like to schedule him to provide training for your organization simply give him a call at […]

Frequent web site updates to be added. In coming weeks we will be adding many more articles in the 5 subject areas noted on the brain map. Stay tuned!

Mindfit soon to be added at a significant discount. If you read Dr. Wells report on the use of MemoryXL in conjunction with Mindfit, you may have wondered what this software does, and how much it costs. For answers to these questions go to their website at: www.Cognifit.com Negotiations are under way to make […]

On July 1st the State of Utah will stop providing the Alzheimer’s drug Aricept® to new Medicaid recipients. However, that should not affect those already on the drug, if it is being effective for them. Aricept, when it is well tolerated, is usually effective for improving memory and reducing related symptoms for approximately 1 to […]